AFRIK - Afrik Pharmaceuticals
|Last Trading Results||Growth & Valuation|
|Opening Price:||--||Earnings Per Share:||--|
|Day's Low Price:||--||Price/Earning Ratio:||--|
|Day's High Price:||--||Dividend Per Share:||--|
|Traded Volume:||0||Dividend Yield:||--|
|Number of Deals:||--||Shares Outstanding:||24.9m|
Monetary values are quoted in Nigerian Naira (NGN) unless otherwise stated
AFRIK Market Performance
AFRIK currently ranks 55th on the Nigerian Stock Exchange in terms of returns to investors with a year-to-date return of zero percent. Following AFRIK are REDSTAREX (-1.14%), AFRIPRUD (-1.37%), and INFINITY (-2.04%). Shareholders are anxiously awaiting when Afrik Pharmaceuticals will announce dividends to see whether they have gained something or not. Below is the historical trading trend of AFRIK, covering up to the last 10 trading sessions of activity.
Profile of Afrik Pharmaceuticals
Afrik Pharmaceuticals operates in the Health Care sector, specifically, the Pharmaceuticals industry—according to the reverse Industry Classification Benchmark (ICB) taxonomy. We are sorry that the names of Afrik Pharmaceuticals's board of directors are temporarily unavailable.
|Factsheet of Afrik Pharmaceuticals|
Industrial Stock Market Competitors
Afrik Pharmaceuticals, issuers of the AFRIK stock on the Nigerian Stock Exchange, have seven market competitors who are also engaged in the Health Care/Pharmaceuticals industry. The table below gives you an overview of their market standing.
|GLAXOSMITH||Glaxo Smithkline Consumer||18.45b||16.80||+0.80|
|MAYBAKER||May & Baker Nigeria||1.44b||1.46||-0.07|
|NEIMETH||Neimeth International Pharma||984.11m||0.58||+0.00|
|EVANSMED||Evans Medical Plc||366.17m||0.50||+0.00|